These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1102660)

  • 1. In vitro and in vivo availability of commercial prednisone tablets.
    Sullivan TJ; Sakmar E; Albert KS; Blair DC; Wagner JG
    J Pharm Sci; 1975 Oct; 64(10):1723-5. PubMed ID: 1102660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of food on the bioavailability of prednisone.
    Tembo AV; Sakmar E; Hallmark MR; Weidler DJ; Wagner JG
    J Clin Pharmacol; 1976; 16(11-12):620-4. PubMed ID: 791973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo bioequivalence of commercial prednisone tablets.
    Francisco GE; Honigberg IL; Stewart JT; Kotzan JA; Brown WJ; Schary WL; Pelsor FR; Shah VP
    Biopharm Drug Dispos; 1984; 5(4):335-44. PubMed ID: 6525441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability and pharmacokinetics of prednisone in humans.
    Disanto AR; Desante KA
    J Pharm Sci; 1975 Jan; 64(1):109-12. PubMed ID: 1133681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative serum prednisone and prednisolone concentrations following prednisone or prednisolone administration to beagle dogs.
    Colburn WA; Sibley CR; Buller RH
    J Pharm Sci; 1976 Jul; 65(7):997-1001. PubMed ID: 957135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability assessment of a liquid prednisone preparation.
    Georgitis JW; Flesher KA; Szefler SJ
    J Allergy Clin Immunol; 1982 Oct; 70(4):243-7. PubMed ID: 7119300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.
    Frey FJ; Rüegsegger MK; Frey BM
    Br J Clin Pharmacol; 1986 Feb; 21(2):183-9. PubMed ID: 3954934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunogassays.
    Meikle AW; Weed JA; Tyler FH
    J Clin Endocrinol Metab; 1975 Oct; 41(4):717-21. PubMed ID: 1176582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of smoking on prednisone, prednisolone, and dexamethasone pharmacokinetics.
    Rose JQ; Yurchak AM; Meikle AW; Jusko WJ
    J Pharmacokinet Biopharm; 1981 Feb; 9(1):1-14. PubMed ID: 7229914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prednisone per os is likely to have limited efficacy in horses.
    Peroni DL; Stanley S; Kollias-Baker C; Robinson NE
    Equine Vet J; 2002 May; 34(3):283-7. PubMed ID: 12108748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two dissolution apparatuses with correlation of in vitro-in vivo data for prednisone and prednisolone tablets.
    Milsap RL; Ayres JW; Mackichan JJ; Wagner JG
    Biopharm Drug Dispos; 1979; 1(1):3-17. PubMed ID: 552859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cimetidine and ranitidine on the conversion of prednisone to prednisolone.
    Sirgo MA; Rocci ML; Ferguson RK; Eshelman FN; Vlasses PH
    Clin Pharmacol Ther; 1985 May; 37(5):534-8. PubMed ID: 3987177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative bioavailability of prednisone and prednisolone in man.
    Tse FL; Welling PG
    J Pharm Pharmacol; 1979 Jul; 31(7):492-3. PubMed ID: 38330
    [No Abstract]   [Full Text] [Related]  

  • 14. Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone.
    Schalm SW; Summerskill WH; Go VL
    Gastroenterology; 1977 May; 72(5 Pt 1):910-3. PubMed ID: 849821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of effect of sucralfate on prednisone bioavailability.
    Gambertoglio JG; Romac DR; Yong CL; Birnbaum J; Lizak P; Amend WJ
    Am J Gastroenterol; 1987 Jan; 82(1):42-5. PubMed ID: 3799579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.
    Powell LW; Axelsen E
    Gut; 1972 Sep; 13(9):690-6. PubMed ID: 4639403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of liquid diet on serum protein binding and prednisolone concentrations after oral prednisone.
    Uribe M; Schalm SW; Summerskill WH; Go VL
    Gastroenterology; 1976 Aug; 71(2):362-4. PubMed ID: 939399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of body condition on plasma prednisolone and prednisone concentrations in clinically healthy cats after single oral dose administration.
    Center SA; Randolph JF; Warner KL; Simpson KW; Rishniw M
    Res Vet Sci; 2013 Aug; 95(1):225-30. PubMed ID: 23473553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peristaltic dissolution apparatus: prediction of relative in vivo performance of prednisone tablets in humans.
    Simmons DL; Legore AA; Picotte P
    J Pharm Sci; 1980 Feb; 69(2):220-2. PubMed ID: 7359333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative bioavailability: eight commercial prednisone tablets.
    Sullivan TJ; Hallmark MR; Sakmar E; Weidler DJ; Earhart RH; Wagner JG
    J Pharmacokinet Biopharm; 1976 Apr; 4(2):157-72. PubMed ID: 950588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.